FDA — authorised 22 November 1951
- Application: NDA050126
- Marketing authorisation holder: WYETH AYERST
- Local brand name: BICILLIN
- Indication: SUSPENSION — ORAL
- Status: approved
🇺🇸 Benzathine Penicillin in United States
FDA authorised Benzathine Penicillin on 22 November 1951
Marketing authorisations
FDA
- Status: approved
FDA
- Application: NDA050128
- Marketing authorisation holder: WYETH AYERST
- Local brand name: BICILLIN
- Indication: TABLET — ORAL
- Status: approved
Benzathine Penicillin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Benzathine Penicillin approved in United States?
Yes. FDA authorised it on 22 November 1951; FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for Benzathine Penicillin in United States?
WYETH AYERST holds the US marketing authorisation.